PUBLIC DISCLOSURE & CLARIFICATION

BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.

CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.

c-MET inhibitor PF-2341066, Purity ≥98%

Inquiry

Cat. No.: X24-06-ZQ221

c-MET inhibitor PF-2341066, Purity ≥98%

Synonym: 877399-52-5; c-MET inhibitor; PF02341066

MDL: MFCD12407409
CAS Number: 877399-52-5
Compound CID: 11626560

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

MSDS

Properties

Description

PF-2341066 inhibits the enzymatic activity of the c-Met tyrosine kinase, the receptor of hepatocyte growth factor/scatter factor (HGF/SF), interfering with pathways leading to cell growth and metastasis. It targets ALK (Karpas299 cells) and c-Met (A549, MDA-MB-231, GTL-16, HT29, 786-O, Colo-205, A498 cells).

Molecular Weight

450.3

Molecular Formula

C₂₁H₂₂Cl₂FN₅O

Targets

ALK (Karpas 299 cells): 24 nM; c-Met: 11 nM

Form

Lyophilized powder

Purity

Identity

Confirmed by NMR/HPLC/MS.

Applications

PF-2341066 is a c-MET inhibitor, applied in studying its role in cancer metastasis and treatment resistance.

Publications

Publications (0)

Publications

Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.